期刊文献+

母细胞性浆细胞样树突细胞肿瘤二例并文献复习 被引量:5

Blastic plasmacytoid dendritic cell neoplasm: two cases report and review of literatures
原文传递
导出
摘要 目的提高对母细胞性浆细胞样树突细胞肿瘤(blastic plasmacytoid dendritic cell neoplasm,BPDC)的认识。方法报道2例BPDC患者,并复习文献总结该病临床及实验室检查特点,介绍肿瘤细胞起源的最新进展。结果2例患者均以皮肤结节起病,肿瘤细胞表达CD4和CD56不表达髓系、T细胞以及B细胞特异性标志。对初始治疗敏感,但迅速复发,病程分别为26、11个月。结论BPDC是少见的淋巴瘤亚型,具有独特的免疫表型,病程呈侵袭性,预后差。近期研究表明肿瘤细胞起源于浆细胞样树突细胞前体细胞。 Objective To identify the clinical and pathological features of blastic plasmacytoid dendritic cell neoplasm (BPDC). Methods The characteristics of BPDC hematodermic neoplasm were discussed with a report of two new cases and review the literatures. Results Both patients presented with skin nodules and the tumors were CD4^+ and CD56^+. Lineage specific markers for B- and T-cell were negative and the tumors did not express myeloperoxidase. Systemic chemotherapy resulted in complete remission, but the disease relapsed quickly and were unresponsive to further chemotherapy. The patients died 26 months and 11 months respectively after diagnosis. Conclusion BPDC hematodermic neoplasm is a rare subtype of lymphoma with distinct clinicopathologic and immunophenotypic features. The disease often has a fulminant course with a poor prognosis. More recent studies suggest that there is a derivation from a plasmacytoid dendritic cell precursor.
出处 《中华内科杂志》 CAS CSCD 北大核心 2009年第3期189-192,共4页 Chinese Journal of Internal Medicine
基金 卫生部临床学科重点项目资助
关键词 浆细胞 树突细胞 杀伤细胞 天然 Plasma cells Dendritic cell Killer cells,natural
  • 相关文献

参考文献12

  • 1Chan JKC, Jaffe ES, Ralfiaer E. Blastic NK-cell lymphoma// Jaffe ES, Harris NL, Stein H, et al. World health organization classification of tumours : Tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001:214-215.
  • 2Jacob MC, Chaperot L, Mossuz P, et al. CD4 + CD56 + lineage negative malignancies : a new entity developed from malignant early plasmacytoid dendritic cells. Haematologica, 2003, 88: 941-955.
  • 3Facchetti F, Jones DM, Petrella T. Blastic plasmacytoid dendritic cell neoplasm//Swerdlow SH, Carapo E, Harris NL, et al. WHO classification of tumours of heamatopioetics and lymphoid tissues. 4th ed. Lyon: IARC Press, 2008 : 145-147.
  • 4Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood, 2005, 105: 3768-3785.
  • 5Adachi M, Maeda K, Takekawa M, et al. High expression of CD56 (N182CAM) in a patient with cutaneous CD4- positive lymphoma. Am J Hematol, 1994, 47:278-282.
  • 6Bekkenk MW, Jansen PM, Meijer CJ, et al. CD56 + hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol, 2004, 15: 1097-1108.
  • 7Wu L, Liu YJ. Development of dendritic-cell lineages. Immunity, 2007, 26 : 741-750.
  • 8Chaperot L, Bendriss N, Manches O, et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood, 2001,97:3210-3217.
  • 9Petrella T, Comeau MR, Maynadie6 M, et al. ‘ Agranular CD4 + CD56 + hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56 + precursor cells related to plasmacytoid monocytes. Am J Surg Pathol, 2002, 26 : 852-862.
  • 10Herling M, Teitell MA, Shen RR, et al. TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4 + CD56 + blastic tumors of skin. Blood, 2003, 101 : 5007-5009.

同被引文献39

  • 1张红梅,张利旺,刘文超,盛蓉,范黎,任军,潘伯荣.右胫前母细胞性NK细胞淋巴瘤1例[J].第四军医大学学报,2006,27(5):395-395. 被引量:1
  • 2纪洪,李甘地,刘卫平,张文燕,李俸媛,李娟,江炜.母细胞性NK细胞淋巴瘤一例[J].中华病理学杂志,2007,36(1):64-66. 被引量:3
  • 3Swerdlow SH, Campo E, Harric NL, et al. WHO classification of tumours ofhaematopoietic and lymphoid tissues. 4rd, Lyon: IARC, 2008: 145-147.
  • 4Jegalian AG, Buxbaum NP, Facchetti F, et al. Blastie plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematologica, 2010, 95: 1873-1879.
  • 5Reizis B, Bunin A, Ghosh HS, et al. Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol, 2011, 29: 163-183.
  • 6Lueioni M, Novara F, Fiandrino G, et al. Twenty-one eases of blastie plasmaeytoid dendritic eel] neoplasm: focus on biallelie locus 9p21.3 deletion. Blood, 2011, 118: 4591-4594.
  • 7Gambiehler T, Pantelaki 1, Stiieker M. Childhood blastie plasmaeytoicl dendritie cell neoplasm treated with allogenie stem cell transplantation. Pediatr Dermatol, 2012 Feb 3. doi: 10.1111/j.1525- 1470.2011.01586.x. [Epub ahead of print].
  • 8Dietrich S, Andmlis M, Hegenhart U, et al. Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatmenl algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity. Biol Blood MmTow Transplant, 2011, 17: 1250-1254.
  • 9Dalle S, Beylot-Bany M, Bagot M. Blastic plasmacytoid dendritic cell neoplasm: is transplanlation the treatment of choice? Br J Dermatol, 2010, 162: 74-79.
  • 10Liu QF, Fan ZP, Zhang Y, et al. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia. Biol Blood Marrow Transplant, 2009,15: 1376- 1385.

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部